Treat-to-target With Secukinumab in Axial Spondyloarthritis
Clinical trial NCT03639740 · UNKNOWN
Trial details
- NCT number
- NCT03639740
- Sponsor
- Professor Mikkel Østergaard
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2021-02-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.